BMS Archive

Plant · Scientific monograph

Eucalyptus globulus

Blue gum eucalyptus

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Respiratory research, Traditional herbal use

Research overview

Historical use

EMA's traditional-use assessment applies to dried eucalyptus leaf preparations for cough associated with colds; it is not a well-established-use conclusion [2].

Modern research context

A meta-analysis of eucalyptus-containing cough products found symptom improvement, but four of six studies used combinations and reviewers judged the clinical importance minimal or uncertain [1].

Adverse effects

The meta-analysis reported no serious adverse events during trial periods and common mild-to-moderate gastrointestinal symptoms in a comparable study; this does not establish safety of every route or oil [1].

Contraindications

Leaf preparations, essential oil and multi-plant inhaled/topical products are distinct. Follow product-specific contraindications; concentrated eucalyptus oil must not be treated as equivalent to leaf tea [1-3].

Clinical and phytochemical data

Used part

Dried leaf for EMA traditional-use scope; some clinical studies used multi-ingredient essential-oil preparations [1-3].

Primary active compounds

  • 1,8-cineole is a principal constituent discussed for eucalyptus oil; leaf and oil preparations differ [1,2].

Mechanism of action

Clinical trials do not establish a single mechanism for the heterogeneous preparations in the cough meta-analysis [1].

Pharmacokinetics

Absorption

Human PK data for the EMA leaf preparations were not identified; route-specific essential-oil studies cannot define leaf PK [1,2].

Distribution

Not characterized for leaf medicines.

Metabolism

Not characterized for leaf medicines.

Excretion

Not characterized for leaf medicines.

Safety and interactions

Drug interactions

No interaction profile can be generalized across the different routes and combination products [1,2].

Toxicity

Trial follow-up does not establish long-term toxicity or the safety of concentrated essential oil [1,2].

Special precautions

Pregnancy

EMA product information does not support medicinal use in pregnancy without adequate data [2].

Lactation

Insufficient medicinal-use evidence in lactation [2].

Hepatic impairment

No impairment-specific data identified.

Renal impairment

No impairment-specific data identified.

Sources and references

  1. [1] Her L et al. Efficacy and Safety of Eucalyptus for Relieving Cough: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Integrative and Complementary Medicine. 2022;28(3):218-226. PMID: 35294302. DOI: 10.1089/jicm.2021.0226.
  2. [2] EMA/HMPC. European Union herbal monograph on Eucalyptus globulus Labill., folium. EMA/HMPC/892618/2011.
  3. [3] Eran Ben-Arye et al. Treatment of upper respiratory tract infections in primary care: a randomized study using aromatic herbs. Evidence-Based Complementary and Alternative Medicine. 2011;2011:690346. PMID: 21052500. DOI: 10.1155/2011/690346.

Additional source links

Continue browsing